A technology platform co-invented by scientists at The Texas Heart Institute in partnership with 7 Hills Pharma CEO and co-founder has been found to improve the effectiveness of vaccines. This pill, described by Director of Molecular Cardiology Research Dr. Peter Vanderslice as a “beautiful way to amplify vaccines” has the potential to be used in various applications, including influenza and coronavirus.

Read Full Story by Alice Levitt on Innovation Map

FUTURE OF PHARMA

Houston immunotherapy company to use $13.5M grant to further develop cancer treatments